News

 

10/22/21 - A true privilege to share our work with Senator Bob Casey

 

9/30/21 - Honored to share our work with Secretary of State Antony Blinken

 

9/15/21 - Wonderful “visiting” the University of Texas at Austin Department of Molecular Biosciences to share our work and hear about the awesome ongoing research there

 

9/2/21 - Finally, a safe, distant pseudo-lab-warming

 

9/1/21 - Thank you to the public who attended the ASV COVID-19 Vaccine Education Town Hall

 

8/26/21 - We had a fanatic time meeting with trainees at Leibniz Institute for Experimental Virology (HPI)

 

8/18/21 - Kevin gains full BSL3 access and select agent clearance

 

8/9/21 - Holly Simmons starts in the laboratory as a research technician. Welcome Holly!

 

4/30/21 - We are now funded to produce improved influenza hemagglutinin immunogens through the NIH CIVICs program via DCVC

 

4/6/21 - Had a great time with the panel of experts for WESA’s "COVID-19: Vaccines, Variants and The Future."

JPEG image-F1855C8EF70B-1.JPEG

 

2/26/21 - One small step for a structural/evolutionary biologist entering BSL3. Not shown: note saying Student->Postdoc->PI->rotation student.

 

2/4/21 - Kevin’s first radio appearance talking SARS-CoV-2 evolution with Rick Dayton at KDKA radio. Some may have thought it would be sports radio. It is great to to speak with the people of our new home.

 

1/19/21 - Wonderful sharing our latest results with MassCPR

IMG_3678 crop.jpg

 

1/6/21 - We exist!

 

 1/6/21 - An honor to present our work to the WHO assay working group

 

1/4/21 - We have emerged!

 

Prologue - Fantastic to begin my independent work at the CVR, remotely. SARS-CoV-2 has changed everything including our research direction.